Moore Michael 4

What Happened

Michael Moore, President of Viemed Healthcare, reported vesting and related transactions on January 29, 2026. A mix of Restricted Stock Units (RSUs) and cash‑settled phantom share units vested (totaling multiple lots of 26,842 and 8,947 shares). To satisfy tax obligations, 7,342 shares were withheld by the issuer (reported as F: tax withholding) valued at $7.48 per share for $54,918. Separately, 8,947 phantom shares were settled for cash to the company at $7.48 per share, producing $66,924. Some derivative‑related items are reported with $0 per‑share amounts reflecting cash settlement mechanics rather than an open‑market sale.

Key Details

• Transaction date: January 29, 2026; Form 4 filed February 2, 2026.
• Reported amounts:
  • 26,842 shares (RSU/derivative) — acquisition/vesting entries reported.
  • 8,947 phantom shares — vested and cash‑settled for $7.48/share = $66,924 (disposition to issuer).
  • 7,342 shares withheld to cover taxes at $7.48/share = $54,918 (tax withholding).
• Price basis: $7.48 per share is the market close price for January 29, 2026 (per filing).
• Transaction codes: M = exercise/conversion of derivative (vesting of RSUs/phantoms); F = shares withheld to satisfy tax liability.
• Shares owned after the transaction: not specified in the supplied data.
• Footnotes: RSUs = contingent rights to one share each; phantom shares are cash‑settled equivalents (see F1–F6 in filing).

Context

• These transactions are compensation‑related (vesting of RSUs and phantom share units) and include routine tax withholding and cash settlement — common for executives receiving equity awards.
• The cash settlement and share withholding are effectively a cashless outcome: the economic value of phantom units was paid to the insider and some vested shares were retained by the company to cover taxes.
• Such events are standard and do not necessarily signal the insider’s market view or a discretionary open‑market sale.